Analyst Ratings For Genus plc (LON:GNS)
Today, Genus plc (LON:GNS) stock received an upgrade by Liberum Capital from Buy.
There are 2 hold ratings, 3 buy ratings on the stock.
The current consensus rating on Genus plc (LON:GNS) is Buy (Score: 2.60) with a consensus target price of GBX 1,470 per share, a potential .
Some recent analyst ratings include
- 3/2/2017-Liberum Capital Upgrade from a “Buy” rating to a “” rating.
- 2/23/2017-N+1 Singer Reiterated Rating of Hold.
- 2/23/2017-Peel Hunt Reiterated Rating of Buy.
- 8/16/2016-HSBC Holdings plc Reiterated Rating of Buy.
- 6/24/2016-Numis Securities Ltd Reiterated Rating of Hold.
About Genus plc (LON:GNS)
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The Company offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.
Recent Trading Activity for Genus plc (LON:GNS)
Shares of Genus plc closed the previous trading session at 1,785.00 up +35.40 2.02% with 45,281 shares trading hands.